(20S)-1alpha-hydroxy-2-methylene-19nor-vitamin D3 and its uses
Details for Australian Patent Application No. 2004266127 (hide)
International Classifications
Event Publications
2 February 2006 PCT application entered the National Phase
PCT publication WO2005/018648 Priority application(s): WO2005/018648
13 April 2006 Amendment Made
The nature of the amendment is: Amend the name of the co-inventor from Rafale R. Sicinski to Sicinski, Rafal R.
19 November 2009 Application Accepted
Published as AU-B-2004266127
18 March 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004266128-Methods, kits and antibodies for detecting parathyroid hormone
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser